Volume 50, Number 2, 490-492, DOI: 10.1007/s00125-006-0545-4

Published in partnership with the

Logo

European Association for the Study of Diabetes

Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure

T. Nakamura, T. Sugaya and H. Koide

View Related Documents

Abstract

Fulltext Preview

Image of the first page of the fulltext document